Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis

European Respiratory Journal

Volumn 37, Issue 5, 2011, Pages 1217-1225

  Maron Gutierrez, T ^a   Castiglione, R C ^a   Xisto, D G ^a   Oliveira, M G ^a   Cruz, F F ^a   Pecanha R ^b   Carreira Jr , H ^a   Ornellas, D S ^a   Moraes, M O ^b   Takiya, C M ^a   Rocco, P R M ^a   Morales, M M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cell therapy; Collagen; Elastance; Macrophages

Indexed keywords

CASPASE 3; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MONONUCLEAR CELL THERAPY; CELL THERAPY; CONTROLLED STUDY; FEMALE; HELPER CELL; LUNG COMPLIANCE; LUNG MECHANICS; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SILICOSIS; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT RESPONSE; Y CHROMOSOME;

ANIMALS; CASPASE 3; FEMALE; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; PULMONARY FIBROSIS; RECEPTORS, INTERLEUKIN-1; SILICON DIOXIDE; SILICOSIS; TRANSFORMING GROWTH FACTOR BETA; Y CHROMOSOME;

EID: 79955665666     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00205009     Document Type: Article

References (29)

1. Greenberg MI, Waksman J, Curtis J. Silicosis: a review. Dis Mon 2007; 53: 394-416. (Pubitemid 47633553)
2. Srivastava KD, Rom WN, Jagirdar J, et al. Crucial role of interleukin-1beta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice. Am J Respir Crit Care Med 2002; 165: 527-533. (Pubitemid 34165477)
3. Hunninghake GW, Kalica AR. Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151: 915-918.
4. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 2003; 100: Suppl. 1, 11917-11923. (Pubitemid 37205904)
5. Ortiz LA, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100: 8407-8411. (Pubitemid 36842558)
6. Rojas M, Xu J, Woods CR, et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005; 33: 145-152. (Pubitemid 41473051)
7. Spees JL, Pociask DA, Sullivan DE, et al. Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis. Am J Respir Crit Care Med 2007; 176: 385-394. (Pubitemid 47267473)
8. Lassance RM, Prota LF, Maron-Gutierrez T, et al. Intratracheal instillation of bone marrow-derived cell in an experimental model of silicosis. Respir Physiol Neurobiol 2009; 169: 227-233.
9. Bates JH, Decramer M, Chartrand D, et al. Volume-time profile during relaxed expiration in the normal dog. J Appl Physiol 1985; 59: 732-737. (Pubitemid 16214133)
10. Weibel ER. Morphometry: stereological theory and practical methods. In: Dekker GJNY, ed. Models of Lung Disease: Microscopy and Structural Methods. New York, Marcel Dekker, 1990; pp. 199-247.
11. Montes GS. Structural biology of the fibres of the collagenous and elastic systems. Cell Biol Int 1996; 20: 15-27. (Pubitemid 26128875)
12. Baleeiro CE, Christensen PJ, Morris SB, et al. GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress. Am J Physiol Lung Cell Mol Physiol 2006; 291: L1246-L1255. (Pubitemid 44904531)
13. Maddox DE, Shibata S, Goldstein IJ. Stimulated macrophages express a new glycoprotein receptor reactive with Griffonia simplicifolia I-B4 isolectin. Proc Natl Acad Sci USA 1982; 79: 166-170. (Pubitemid 12181507)
14. Borges VM, Falcao H, Leite-Junior JH, et al. Fas ligand triggers pulmonary silicosis. J Exp Med 2001; 194: 155-164.
15. Faffe DS, Silva GH, Kurtz PM, et al. Lung tissue mechanics and extracellular matrix composition in a murine model of silicosis. J Appl Physiol 2001; 90: 1400-1406. (Pubitemid 32220925)
16. Borges VM, Lopes MF, Falcao H, et al. Apoptosis underlies immunopathogenic mechanisms in acute silicosis. Am J Respir Cell Mol Biol 2002; 27: 78-84. (Pubitemid 34657394)
17. Rimal B, Greenberg AK, Rom WN. Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med 2005; 11: 169-173. (Pubitemid 40279926)
18. Huaux F. New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol 2007; 7: 168-173. (Pubitemid 46411518)
19. Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007; 104: 11002-11007. (Pubitemid 47175216)
20. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10: 89-102.
21. Lalmanach G, Diot E, Godat E, et al. Cysteine cathepsins and caspases in silicosis. Biol Chem 2006; 387: 863-870. (Pubitemid 44100232)
22. Shen HM, Zhang Z, Zhang QF, et al. Reactive oxygen species and caspase activation mediate silica-induced apoptosis in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2001; 280: L10-L17.
23. Delgado L, Parra ER, Capelozzi VL. Apoptosis and extracellular matrix remodelling in human silicosis. Histopathology 2006; 49: 283-289. (Pubitemid 44253618)
24. Jagirdar J, Begin R, Dufresne A, et al. Transforming growth factorbeta (TGF-beta) in silicosis. Am J Respir Crit Care Med 1996; 154: 1076-1081.
25. Barbarin V, Arras M, Misson P, et al. Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am J Respir Cell Mol Biol 2004; 31: 78-85. (Pubitemid 38888042)
26. Zhang Y, Lee TC, Guillemin B, et al. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 1993; 150: 4188-4196. (Pubitemid 23129800)
27. Kumamoto M, Nishiwaki T, Matsuo N, et al. Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. Eur Respir J 2009; 34: 740-748.
28. Aguilar S, Scotton CJ, McNulty K, et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS ONE 2009; 4: e8013.
29. Fischer UM, Harting MT, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2009; 18: 683-692.